Figure 1: (a) Positron emission tomography–computed tomography scan showed fluorodeoxyglucose-avid soft tissue mass involving nasopharynx. (b) Contouring images with Gross tumor volume - blue, Clinical target volume - green, Planning target volume - red. (c) Color wash showing 95% coverage of planning target volume by prescribed dose. (d) Dose Volume Histogram showing Organ at risks and Planning target volume coverage [details in Supplementary Table 1]
![Figure 1: (a) Positron emission tomography–computed tomography scan showed fluorodeoxyglucose-avid soft tissue mass involving nasopharynx. (b) Contouring images with Gross tumor volume - blue, Clinical target volume - green, Planning target volume - red. (c) Color wash showing 95% coverage of planning target volume by prescribed dose. (d) Dose Volume Histogram showing Organ at risks and Planning target volume coverage [details in Supplementary Table 1]](articles/2023/14/1/images/JRadiatCancerRes_2023_14_1_43_353193_f1.jpg)